Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: A placebo-controlled trial

Hepatology

Volumn 25, Issue 1, 1997, Pages 241-244

  Lai, Ching Lung ^a   Ching, Chi Kong ^a   Tung, Angus Kwong Ming ^a   Li, Eileen ^c   Young, John ^a   Hill, Andrew ^b   Wong, Benjamin Chun Yu ^a   Dent, Julie ^b   Wu, Pui Chee ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b GLAXOSMITHKLINE   (United Kingdom)

^c MVA Hong Kong Ltd   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN; LAMIVUDINE; VIRUS DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HEPATITIS B; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VIRUS CARRIER; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0031021902     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250144     Document Type: Article

References (18)

1. Maynard JE, Kare MA, Alter MJ, Hadler SC. Control of hepatitis B ly immunization: global perspective. In: Zuckerman AJ, ed. Viral hepatitis and liver disease. New York: Liss, 1988:967-969.
2. Beasley RP. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma: epidemiologic considerations. HEPATOLOGY 1982;2:S21-S26.
3. Margolis HS, Alter MJ, Hadler SC. Hepatitis B. Evolving epidemiology and implications for control. Semin Liver Dis 1991;11:84-92.
4. Wong DKH, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis Be antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med 1993;119: 312-323.
5. 2 interferon in Chinese HBsAg carrier children. Lancet 1987;2:877-880.
6. 2 interferon in Chinese patients with chronic hepatitis B infection. Lancet 1988;6:298-302.
7. 2 interferon with or without prednisone in Chinese HBsAg carrier children. Q J Med 1991;78:155-163.
8. Lok ASF, Wu PC, Lai CL, Lau JYN, Leung EKY, Wong LSK, Ma OCK, et al. A controlled trial of interferon with or without prednisone priming for chronic hepatitis B. Gastroenterology 1992;102:2091-2097.
9. Chen D-S. Natural history of chronic hepatitis B virus infection: new light on an old story. J Gastroenterol Hepatol 1993;8:470-475.
10. Furman PA, Davis M, Liotta DC, Paff M, Frick LW, Nelson DJ, Domsife RE, et al. The anti-hepatitis B virus activities, cytotoxicities and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2(hydroxymethyl)-1,3-oxanthiolan-5-yl] cytosine. Antimicrob Agents Chemother 1992;36: 2686-2692.
11. Chang CN, Doong S-L, Zhour JH, Beach JW, Jeong LS, Chu CK, Tsai CH, et al. Deoxycytidine deaminase-resistant stereoisomer is the active form of (±)-2′3′-dideoxy-3′-thiacytidine in the inhibition of hepatitis B virus replication. J Biol Chem 1992;267:13938-13942.
12. Tyrell DLJ, Fischer K, Savani K, Tan W, Jewell L. Treatment of chimpanzees and ducks with lamivudine, 2′,3′ dideoxy 3′ thiacytidine results in a rapid suppression of hepadna viral DNA in sera [Abstract]. Clin Invest Med 1993;16:B77.
13. Gonzalez-Peralta R, Andres JM, Tung FY, Fang JWS, Brunson ME, Davis GL, Lau JYN. Transplantation of a hepatitis B surface antigen-positive donor liver into a hepatitis B virus-negative recipient. Transplantation 1994;58:114-116.
14. Dienstag JL, Perillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995;333:1657-1661.
15. Tyrrell DLJ, Mitchell MC, De Man RA, Schalm SW, Main J, Thomas HC, Fevery J, et al. Phase II trial of lamivudine for chronic hepatitis B [Abstract]. HEPATOLOGY 1993;18:112A.
16. McKenzie R, Fried MW, Sallie R, Conjeevaram H, Di Bisceglie AM, Park Y, Savarese B, et al. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med 1995;333:1099-1105.
17. Cui L, Yoon S, Schinazi RF, Sommadossi J-P. Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-β-D-arabinofuranosyl)-5-iodouracil in human liver cells. J Clin Invest 1995;95:555-563.
18. Perillo RP. Factors influencing response to interferon in hepatitis B. Implications for Asian and Western populations. HEPATOLOGY 1990;12:1433-1434.